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Abstract
© The Author(s) 2017. Vitamin D has been suggested to have a role in various neurovascular
diseases, but the data regarding headache is inconclusive. Our aim was to investigate the
associations between serum 25-hydroxyvitamin D [25(OH)D], a marker for vitamin D status, and
risk of frequent headache. The study population consisted of 2601 men from the population-
based Kuopio Ischaemic Heart Disease Risk Factor Study (KIHD) from eastern Finland, aged 42-
60  years  in  1984-1989.  The  cross-sectional  associations  with  prevalence  of  self-reported
frequent headache (defined as weekly or daily headaches) were estimated with multivariable-
adjusted odds ratios. The average serum 25(OH) concentration was 43.4 nmol/L (SD 18.9, min-
max 7.8-136.1 nmol/L). A total of 250 men (9.6%) reported frequent headache. The average
serum 25(OH)D concentration among those with frequent headache was 38.3 nmol/L (SD 18.8)
and 43.9 nmol/L (SD 18.9) among those without frequent headache, after adjustment for age
and year and month of blood draw (P for difference < 0.001). After multivariable adjustments,
those in the lowest vs. the highest serum 25(OH)D quartile had 113% (95% CI 42, 218%; P for
trend  <  0.001)  higher  odds  for  frequent  headache.  In  conclusion,  low  serum  25(OH)D
concentration was associated with markedly higher risk of frequent headache in men.
http://dx.doi.org/10.1038/srep39697
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